Hopp til hovedinnhold

Intravenøs immunglobulin (IVIG)

Sist oppdatert: Sist revidert:
Sist revidert av:
  1. J Peripher Nerv Syst. . A proposed dosing algorithm for the individualized dosing of human immunoglobulin in chronic inflammatory neuropathies. J Peripher Nerv Syst. 2016. pmid:26757367 PubMed  
  2. Sandler SG, Eder AF, Goldman M, Winters JL. The entity of immunoglobulin A-related anaphylactic transfusion reactions is not evidence based. Transfusion. 2015 Jan;55(1):199-204. doi: 10.1111/trf.12796. Epub 2014 Jul 28. PMID: 25066014. PubMed  
  3. Abbas A, Rajabally YA.. Complications of Immunoglobulin Therapy and Implications for Treatment of Inflammatory Neuropathy: A Review.. Curr Drug Saf 2019; 14(1):: 3-13. pmid:30332974 PubMed  
  4. Kapoor M, Spillane J, Englezou C, Sarri-Gonzalez S, Bell R, Rossor A, Manji H, Reilly MM, Lunn MP, Carr A. Thromboembolic risk with IVIg: Incidence and risk factors in patients with inflammatory neuropathy. Neurology. 2020 Feb 11;94(6):e635-e638. doi: 10.1212/WNL.0000000000008742. Epub 2019 Dec 18. PMID: 31852814 PubMed  
  5. Kapoor M, Hunt I, Spillane J, Bonnett LJ, Hutton EJ, McFadyen J, Westwood JP, Lunn MP, Carr AS, Reilly MM. IVIg-exposure and thromboembolic event risk: findings from the UK Biobank. J Neurol Neurosurg Psychiatry. 2022 Aug;93(8):876-885. doi: 10.1136/jnnp-2022-328881. Epub 2022 Jun 10. PMID: 35688633. PubMed  
  6. Totzeck A, Stettner M, Hagenacker T.. Early platelet and leukocyte decline in patients with neuroinflammatory disorders after intravenous immunoglobulins. Eur J Neurol. 2017; Apr;24(4): 638-644. pmid: 28224702 PubMed  
  7. International Journal of Clinical Transfusion Medicine Intravenous immunoglobulin-associated hemolysis: risk factors, challenges, and solutions Muhajir Mohamed nevro.legehandboka.no  
  8. Grüter T, Ott A, Meyer W, Jarius S, Kinner M, Motte J, Pitarokoili K, Gold R, Komorowski L, Ayzenberg I. Effects of IVIg treatment on autoantibody testing in neurological patients: marked reduction in sensitivity but reliable specificity. J Neurol. 2020 Mar;267(3):715-720. doi: 10.1007/s00415-019-09614-4. Epub 2019 Nov 14. PMID: 31728710. PubMed  
  9. Živković S.. Intravenous immunoglobulin in the treatment of neurologic disorders.. Acta Neurol Scand 2015. pmid:25997034 PubMed  
  • Åse Mygland, spesialist i nevrologi, professor, dr med
  • Christian Vedeler, spesialist i nevrologi, professor, dr med
  • Unn Ljøstad, spesialist i nevrologi, professor, PhD